"As genetic tests become increasingly accessible, they're helping transform health care by connecting patients with more personalized diagnoses and treatments. But it's often challenging for health plans to decide whether to pay for them. One prime example can be found in obstetrics, where cell-free DNA-based noninvasive prenatal testing (NIPT) has been rising in popularity among patients and clinicians alike, yet payers differ in terms of how they cover it."  MORE >>